High persistence and adherence among NOAC users Adequate persistence and adherence with non-vitamin K antagonists (NOACs) is essential for optimal stroke prevention in atrial fibrillation (AF), but large-scale studies comparing the different NOACs has been lacking. In a study recently… Read More ›
More than 50 researchers from Norway, Sweden, Denmark, Germany, The Netherlands, UK and Canada connected for a workshop on Atrial Remodeling in AF on Thursday April 15. The meeting started with one of the keynote speakers, dr. Pyotr Platonov who… Read More ›
News on AF screening from afib.no network members: “Research Priorities in Atrial Fibrillation Screening” – Emelia J. Benjamin, Renate B. Schnabel, Isabelle C. Van Gelder et al.
Our colleagues Emelia Benjamin, Renate Schnabel and Isabelle C. Van Gelder has spearheaded this report from the U.S. National Heart, Lung, and Blood institute. It gives a nice overview of the current status of AF screening and highlights the knowledge… Read More ›
The Norwegian EXercise and Atrial Fibrillation Study (NEXAF) is a collaborative project within afib.no addressing research questions related to exercise and atrial fibrillation. The project includes three main work packages: Work package 1 is a randomized controlled trial of a… Read More ›
Several afib.no network members are involved in the OMega-3 fatty acids in Elderly with Myocardial Infarction (OMEMI) trial, investigating the effect of n-3 polyunsaturated fatty acids in patients aged 70-82 with recent myocardial infarction. The results were presented by Are… Read More ›
We congratulate Vegard Malmo on winning the prize for best thesis at KlinForsk’s webinar on “International Clinical Trials Day” May 20, 2020, with his thesis: Atrial Fibrillation and exercise. Read more here. (Norwegian page)